Advisory Committees

January 24, 2018: Tobacco Products Scientific Advisory Committee Meeting Announcement



January 24, 2018 - 8:30 a.m. to 5:00 p.m.

FDA White Oak Conference Center
Building 31, Room 1503
10903 New Hampshire Ave.
Silver Spring, MD 20993-0002


Seating for this meeting may be limited, so the public is encouraged to watch the free webcast instead of traveling to the meeting.  The link for the webcast will be available approximately 15 minutes prior to the beginning of the meeting each day and can be accessed in the Tobacco Products Scientific Advisory Committee section.


On January 24-25, 2018, the Committee will discuss modified risk tobacco product applications (MRTPAs), submitted by Philip Morris Products S.A. for IQOS system with Marlboro Heatsticks, IQOS system with Marlboro Smooth Menthol Heatsticks, and IQOS system with Marlboro Fresh Menthol Heatsticks.

Meeting Materials

FDA intends to make the background material available to the public on its website no later than 2 business days before the meeting. If FDA is unable to post the background material on its website prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and will be posted on FDA’s website after the meeting.

Public Participation Information

Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee.

Written submissions may be made to the contact person on or before January 4, 2018.  Please send 20 paper copies, and one electronic copy, of your submission to:

Caryn Cohen
Office of Science
Center for Tobacco Products
Food and Drug Administration
Document Control Center
Bldg. 71, Rm. G335
10903 New Hampshire Ave.
Silver Spring, MD 20993–0002

Copies must be received by 4 p.m. (Eastern) on January 4, 2018.

Oral presentations from the public will be scheduled between approximately 8 a.m. and 9 a.m. on January 25, 2018.  Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before December 27, 2017. 

Time allotted for each presentation may be limited.  If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session.  The contact person will notify interested persons regarding their request to speak by December 28, 2017.

Contact Information

Caryn Cohen
Office of Science
Center for Tobacco Products
Food and Drug Administration
Document Control Center, Bldg. 71, rm. G335
10903 New Hampshire Ave.
Silver Spring, MD 20993-0002

Phone: 1-877-287-1373 (choose Option 5) 
FDA Advisory Committee Information Line
301-443-0572 in the Washington DC area

A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice.  Therefore, you should always check the agency’s Website and call the appropriate advisory committee hot line/phone line to learn about possible modifications before coming to the meeting.

Persons attending FDA’s advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets.  FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs.  If you require special accommodations due to a disability, please contact Caryn Cohen at least 7 days in advance of the meeting.  FDA is committed to the orderly conduct of its advisory committee meetings. 

Please visit our Advisory Committees section for procedures on public conduct during advisory committee meetings.

Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app.2).

Page Last Updated: 06/21/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English